Better Fintech Stock: Upstart vs. Affirm

Both Upstart (UPST) and Affirm (AFRM) shares are down roughly 36% year-to-date and currently trade at about 58x earnings (down from Dec P/Es of 168 for Upstart and 107 for Affirm). Recent fundamentals show strong growth: Upstart originations +86%, revenue +64%, and $18.6M net income (third straight profitable quarter); Affirm GMV +36%, revenue +30%, and net income +61% y/y. Key near-term catalysts are both firms' bank charter applications (Affirm: industrial loan charter applied in January; Upstart: full-service national bank), which could lower funding costs and enable direct lending, but valuation concerns and potential credit-quality deterioration/defaults in 2026 remain material risks.

Analysis

Upstart's optionality is asymmetric: its AI underwriting is a scalable, low incremental cost product while a bank charter converts a fee business into a capital-intensive NII engine. If deposit funding reduces wholesale funding costs by ~200–400bps versus current warehouse/ABS funding, this could translate into a 150–300bps improvement in NIM-equivalent returns on originated assets and a 20–50% uplift to run-rate EPS within 12–24 months, materially re-rating an earnings multiple priced for stalled growth.

But the path is binary and timing-sensitive. Charter approval, systems build, compliance and capital raises will take 6–18 months and carry execution risk; conversely, a mild macro-driven credit shock (a 150–300bps increase in net charge-offs) could erase the charter benefit and compress EPS by a similar magnitude inside a single cycle. The bank-charter narrative is a catalyst but not an earnings hedge — approval simply shifts the locus of risk from partners to the company.

Competitive second-order effects: incumbent banks face lower incentive to rebuild AI from scratch if outsourcing remains cheaper than hiring data-science and credit risk teams, which keeps Upstart’s pricing power intact. But large banks could also negotiate lower platform fees or accelerate internal models if they view the charter as a threat, making revenue dilution a 12–36 month tail risk. BNPL operators (Affirm) face a tougher relative outlook because their product sits higher in unsecured consumer elasticity; funding-cost compression helps, but credit cyclicality and merchant economics limit margin recovery.

Net: market has pre-priced headline credit fears; upside is concentrated in the charter execution and NIM recovery, downside is concentrated in credit shocks and regulatory/frictional delays. Position sizing should reflect a binary outcome with staged entry keyed to observable milestones (approval newsflow, deposit beta, ABS spread tightening).

Key Decisions for Investors

• Pair trade (6–12 months): Long UPST equity (1–2% portfolio) / Short AFRM equal notional (1–2%) to express asymmetric optionality — target +60–120% relative upside if UPST executes charter and NIM improves; downside ~40–60% if credit stress materializes. Trim on UPST after +30% move or on AFRM weakness beyond -40%.
• Event-driven options (6–18 months): Buy a UPST call spread (buy 9–12 month ATM call, sell 30–50% OTM call) sizing premium = 0.5–1% portfolio for ~3:1 asymmetric payoff if charter approval and deposit beta realization occur; max loss limited to premium.
• Hedge credit tail (3–12 months): Buy short-dated UPST puts ~15% OTM (~0.2–0.5% portfolio) or buy protection on consumer ABS/credit ETFs to cap losses from a surge in net charge-offs — cost justified as insurance if macro data surprises to the downside.
• Tactical short (0–6 months): Sell AFRM into rallies or buy deep OTM puts if consumer delinquencies accelerate; expect limited upside from funding changes vs higher exposure to unsecured credit losses — target asymmetric payoff where premium is <0.5% portfolio and potential payoff >3x if default wave occurs.